131 results
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
25 Jan 24
Other Events
5:00pm
are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking … Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may
S-1/A
EX-10.9
SABS
SAB Biotherapeutics Inc
4 Jan 21
IPO registration (amended)
5:20pm
of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed
8-K
EX-10.3
SABS
SAB Biotherapeutics Inc
12 Jan 21
Big Cypress Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
4:10pm
of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
6 Jun 22
Other Events
1:35pm
are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
12 Dec 22
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
9:07am
that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act
8-K
59ek669 xy4c
30 Sep 22
Regulation FD Disclosure
9:12am
8-K
8pnkh1m7wf1
15 Apr 24
Regulation FD Disclosure
5:15pm
8-K
EX-99.2
tcb 9pj39n9hnrp
23 Sep 22
Regulation FD Disclosure
8:59am
POS AM
g8ehw21lgmqhong
20 Apr 22
Prospectus update (post-effective amendment)
4:56pm
8-K
EX-99.1
rna9ey785q2jai03o2f5
20 Nov 23
SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors
5:00pm
8-K
sn5z1s
23 Sep 22
Regulation FD Disclosure
8:59am
8-K
vyt6s4f9 4pu
5 Jul 22
Regulation FD Disclosure
4:31pm
8-K
kex1nk49vdmch
21 May 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
8-K
ykrnh2g4e2je
12 May 23
Regulation FD Disclosure
5:17pm
8-K
nio6t1b47 12sukm1d
14 Jun 23
Regulation FD Disclosure
8:53am
424B3
l1z8k2y
29 Apr 22
Prospectus supplement
4:16pm
8-K
gw0oma1d3mhwufm uapq
1 Nov 22
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership
5:06pm
8-K
utggu8ibiy
19 Jan 24
Regulation FD Disclosure
4:21pm